【GPCR】AI生技新創《Antiverse》完成460萬美元融資，瞄準「G蛋白偶合受體(GPCR)」和「離子通道」開發
文章出處
The American Bazaar
原文標題
AI-driven biotech startup Antiverse raises $4.6 million, investors include Innospark
Twitter
https://x.com/aimedadviser/status/1848870334877078034
文章序號
6505
智醫科學－AI醫療技術、應用與市場動態
Copyright ©2024 智醫科學 MEDai.tw All rights reserved.
The content of
this site is intended for healthcare and medical professionals.
